Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using a new device to prevent radial artery occlusion after catheterization

Official title: A Prospective Registry for the Evaluation of the Safety, Efficacy and Clinical Impact of the Double Hemostasis System Terry2 (TM) on Patients Undergoing a Trans-radial or Trans-cubital Catheterism.

Run by Laval University · NCT04933136 · Data updated 2026-11-12

This study is testing a new band to see if it can help prevent blockage in the wrist artery after heart procedures, making it safer and more comfortable for patients.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorLaval University
Academic / other
Locations5 sites (Chicoutimi, Quebec and 4 other locations)
StatusRecruiting
StartedDecember 12, 2022
Main results expectedSeptember 30, 2025
Study endsDecember 31, 2025
Registry record updatedMarch 10, 2025
Trial IDNCT04933136 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients referred for diagnostic or interventional catheterization via radial or cubital approaches.

Probably not a fit

Patients with local conditions like hematomas or pseudo-aneurysms that prevent radial or cubital access may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness and safety of the Terry2™ band in achieving non-occlusive hemostasis of the radial artery after transradial catheterization. The study focuses on improving patient comfort and minimizing the risk of radial artery occlusion (RAO), a common complication that can limit future access to the artery. By applying simultaneous pressure to both the radial and cubital arteries, the Terry2™ band aims to reduce the incidence of RAO to less than 2%. The study will involve patients undergoing diagnostic or interventional catheterization through radial or cubital approaches.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the risk of radial artery occlusion, improving future access for catheterization and surgical procedures.

How similar studies have gone: While the concept of non-occlusive hemostasis has been explored, the use of the Terry2™ band represents a novel approach that has not been widely tested in clinical settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Any patient referred for diagnostic or interventional catheterization through radial or cubital approach

Exclusion Criteria:

* Unable to understand the study design and sign an informed consent
* Unable to receive antiplatelet therapy with aspirin and/or clopidogrel-prasugrel and/or ticagrelor and intravenous anticoagulant treatment with heparin or bivalirudin
* Presence of any local conditions like hematoma or pseudo-aneurysms precluding radial or cubital access.
* Presence of PPG while simultaneously compressing the radial and cubital arteries (due to collateral branches or interosseous artery), which prevents the establishment of non-occlusive hemostasis with the Terry2(TM) band.

Where it's running

  • IUCPQ - Laval Hospital
    Québec, Quebec, Canada
    Recruiting
  • CSSS Chicoutimi
    Chicoutimi, Quebec, Canada
    Not yet recruiting
  • CHUM- Centre hospitalier de l'Université de Montréal
    Montreal, Quebec, Canada
    Not yet recruiting
  • CHU de Québec
    Québec, Quebec, Canada
    Not yet recruiting
  • Hôpital Sainte-Marie
    Trois-Rivières, Quebec, Canada
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.